Vitamin C: should we supplement?

Curr Opin Crit Care. 2018 Aug;24(4):248-255. doi: 10.1097/MCC.0000000000000510.


Purpose of review: Hypovitaminosis C and vitamin C deficiency are very common in critically ill patients due to increased needs and decreased intake. Because vitamin C has pleiotropic functions, deficiency can aggravate the severity of illness and hamper recovery.

Recent findings: Vitamin C is a key circulating antioxidant with anti-inflammatory and immune-supporting effects, and a cofactor for important mono and dioxygenase enzymes. An increasing number of preclinical studies in trauma, ischemia/reperfusion, and sepsis models show that vitamin C administered at pharmacological doses attenuates oxidative stress and inflammation, and restores endothelial and organ function. Older studies showed less organ dysfunction when vitamin C was administered in repletion dose (2-3 g intravenous vitamin C/day). Recent small controlled studies using pharmacological doses (6-16 g/day) suggest that vitamin C reduces vasopressor support and organ dysfunction, and may even decrease mortality.

Summary: A short course of intravenous vitamin C in pharmacological dose seems a promising, well tolerated, and cheap adjuvant therapy to modulate the overwhelming oxidative stress in severe sepsis, trauma, and reperfusion after ischemia. Large randomized controlled trials are necessary to provide more evidence before wide-scale implementation can be recommended.

Publication types

  • Review

MeSH terms

  • Antioxidants / administration & dosage*
  • Ascorbic Acid / administration & dosage*
  • Ascorbic Acid / blood
  • Ascorbic Acid Deficiency / diet therapy*
  • Critical Care*
  • Critical Illness / therapy*
  • Humans
  • Nutritional Requirements / physiology
  • Organ Dysfunction Scores
  • Oxidative Stress / drug effects*
  • Treatment Outcome


  • Antioxidants
  • Ascorbic Acid